<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05004168</url>
  </required_header>
  <id_info>
    <org_study_id>CRSU.P.SPF_Paragon/02.20/07.03</org_study_id>
    <nct_id>NCT05004168</nct_id>
  </id_info>
  <brief_title>Sun Protection Factor (SPF) / UVA Protection Factor Study</brief_title>
  <official_title>The Efficacy of Sun Protection Factor (SPF) Against UV-B and UV-A of Cosmetic Products</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>PT Paragon Technology and Innovation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the effectiveness of sunscreen products by determining its Sun Protection&#xD;
      Factor (SPF) against UV-B and UV-A&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sunscreen is intended to protect the skin from sun burn but since the amount of protection&#xD;
      needed varies among individuals, sunscreen manufactures offer consumers difference levels of&#xD;
      protection. These different levels of protection are expressed as a numerical value called&#xD;
      the sun protection factor or SPF. The SPF is the ratio between the minimal erythema dose&#xD;
      (MED) of sunscreen product of the protected skin and the MED of the unprotected skin. The&#xD;
      minimal erythema dose in human skin is defined as the lowest ultraviolet B (UV-B) dose&#xD;
      produces the first perceptible unambigous erythema with defined border appearing over most of&#xD;
      the field of UVB exposure 16 - 24 hours after UVB exposure.&#xD;
&#xD;
      The UVA protection factor is the ratio between the Minimal Persistent Pigmentation Darkening&#xD;
      Dose (MPPDD) of sunscreen product of the protected skin and the MPPDD of the unprotected&#xD;
      skin. The threshold response will be taken as an unequivocal pigment darkening with distinct&#xD;
      border which persisted for at least 2 hours.&#xD;
&#xD;
      The test products are Day Gel-0120-C and Day Gel-0120-D with active ingredients ethylhexyl&#xD;
      methoxycinnamate, Diethylamino hydroxybenzoyl hexyl benzoate&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2, 2020</start_date>
  <completion_date type="Actual">September 24, 2020</completion_date>
  <primary_completion_date type="Actual">September 24, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To measure the SPF Value of the teat product</measure>
    <time_frame>2-24 hours post exposure</time_frame>
    <description>The mean of SPF value from all the subject</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Sunscreen Agents</condition>
  <arm_group>
    <arm_group_label>SPF evaluation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy male or female subjects with Fitzpatrick Skin Type of II-IV were included in the SPF study</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Day Gel-0120</intervention_name>
    <description>Two milligrams of test article applied to the test area. The test products are Day Gel-0120C and Day Gel-0120-D. The products are applied together on the test area with</description>
    <arm_group_label>SPF evaluation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>P5 Reference Standard (SPF 35 reference)</intervention_name>
    <description>The reference product is P5 according to ISO 24444:2019. The application of reference product is similar with test product.</description>
    <arm_group_label>SPF evaluation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          1. Healthy male or female, 18-60 years of age&#xD;
&#xD;
          2. Fair skin with skin type II-IV of Fitzpatrick's skin type&#xD;
&#xD;
          3. Able to understand and comply to the investigators instruction.&#xD;
&#xD;
          4. Able to read, understand and sign up informed consent form.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          1. Subject with a history of abnormal response to sunlight or those taking medication&#xD;
             which might produce an abnormal response to sunlight&#xD;
&#xD;
          2. Subject exhibiting current sun burn, sun tan, uneven skin tone, or visible skin&#xD;
             disease which might be confused with a reaction from the test material or which might&#xD;
             interfere with evaluation of test results&#xD;
&#xD;
          3. Individuals who are under doctor's care&#xD;
&#xD;
          4. Female subjects who indicate that they are pregnant or nursing&#xD;
&#xD;
          5. Individuals with known hypersensitivity to any sunscreen products&#xD;
&#xD;
          6. Individuals accustomed to using tanning beds&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frans Suyatna, Prof, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Research Supporting Unit, Faculty of Medicine, University of Indonesia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Research Supporting Unit</name>
      <address>
        <city>Jakarta Pusat</city>
        <state>DKI Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <link>
    <url>https://www.iso.org/standard/72250.html</url>
    <description>ISO 24444:2019-Sun Protection test methods-in vivo determination of the Sun Protection Factor (SPF)</description>
  </link>
  <link>
    <url>https://www.iso.org/standard/46521.html</url>
    <description>Sun protection test methods-In vivo determination of sunscreen UVA protection</description>
  </link>
  <reference>
    <citation>Heckman CJ, Chandler R, Kloss JD, Benson A, Rooney D, Munshi T, Darlow SD, Perlis C, Manne SL, Oslin DW. Minimal Erythema Dose (MED) testing. J Vis Exp. 2013 May 28;(75):e50175. doi: 10.3791/50175.</citation>
    <PMID>23748556</PMID>
  </reference>
  <reference>
    <citation>Donglikar MM, Deore SL. Sunscreens: A review. Pharmacognosy Journals. 2016;8(3):171-179</citation>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 8, 2021</study_first_submitted>
  <study_first_submitted_qc>August 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2021</study_first_posted>
  <last_update_submitted>August 11, 2021</last_update_submitted>
  <last_update_submitted_qc>August 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>Prof. dr. Franciscus D. Suyatna, PhD, SpFK</investigator_full_name>
    <investigator_title>Clinical Pharmacology Professor</investigator_title>
  </responsible_party>
  <keyword>Sun Protection Factor</keyword>
  <keyword>Sunscreen</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

